Role of endogenous endothelin in the regulation of basal coronary tone in the rat
| Autor: | Mohamed Amrani, Andrew T. Goodwin, Jay Jayakumar, Magdi H. Yacoub, Caroline C. Gray |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Endothelin Receptor Antagonists
Male medicine.medical_specialty Patch-Clamp Techniques Physiology Vasodilation Endogeny In Vitro Techniques Muscle Smooth Vascular Membrane Potentials Nitric oxide Rats Sprague-Dawley chemistry.chemical_compound Internal medicine medicine Animals Enzyme Inhibitors Receptor Coronary sinus business.industry Endothelins Cardiac muscle Original Articles Receptor Endothelin A Coronary Vessels Epoprostenol Receptor Endothelin B Electric Stimulation Rats Electrophysiology medicine.anatomical_structure Endocrinology chemistry Muscle Tonus Nitric Oxide Synthase business Endothelin receptor Perfusion |
| Zdroj: | The Journal of Physiology. 511:549-557 |
| ISSN: | 0022-3751 |
| DOI: | 10.1111/j.1469-7793.1998.549bh.x |
| Popis: | 1. Coronary vascular tone is a vital factor that regulates the delivery of oxygen to cardiac muscle. We tested the hypothesis that basal coronary tone may depend on the release of an endogenous vasoconstrictor peptide, endothelin (ET). 2. Using an isolated, Krebs solution-perfused rat heart we measured the changes in coronary flow following the administration over a 30 min period of the ET antagonists Ro61-0612 (mixed ETA/ETB), PD155080 (ETA) and BQ788 (ETB). 3. In a second series of experiments, hearts were randomly assigned to perfusion with plain Krebs solution, or with Krebs solution to which L-NAME and/or indomethacin had been added. The effect on coronary flow following the addition of Ro61-0612 was then measured. 4. Perfusion with Ro61-0612 (10-4 M) alone increased coronary flow by 57.8 % vs. control (P = 0.00001). PD155080 (10-4 M) increased coronary flow by 28.9 % (P = 0.009), whereas BQ788 had no effect on coronary flow. 5. In the second series of experiments, Ro61-0612 increased coronary flow by 6.6 +/- 0.8 ml min-1 in hearts perfused with plain Krebs solution, by 3.8 +/- 0.8 ml min-1 in hearts to which both L-NAME and indomethacin had been added, by 3.3 +/- 0.7 ml min-1 in hearts to which L-NAME had been added, and by 6. 9 +/- 0.5 ml min-1 in hearts to which indomethacin had been added to the Krebs buffer. 6. In hearts perfused with Krebs solution alone, nitric oxide (NO) release into the coronary sinus increased from 219. 8 to 544.9 pmol min-1 g-1 following the addition of Ro61-0612 (P = 0. 06). There was no detectable release of NO from hearts perfused with L-NAME alone or in combination with indomethacin either before or after the addition of Ro61-0612. 7. We conclude that endogenous ET plays a role in coronary tone mediated via ETA receptors. This vasodilatation is partially due to an increase in endogenous NO release. However, a significant vasodilatation is still seen following the inhibition of NO synthesis. We propose that basal coronary tone depends on a balance between the endogenous release of vasodilators such as NO and vasoconstrictors such as ET. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text